Literature DB >> 26343748

Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.

Gregory A Hawkins1, David J Friedman, Lingyi Lu, David R McWilliams, Jeff W Chou, Satria Sajuthi, Jasmin Divers, Rulan S Parekh, Man Li, Giulio Genovese, Martin R Pollack, Pamela J Hicks, Donald W Bowden, Lijun Ma, Barry I Freedman, Carl D Langefeld.   

Abstract

BACKGROUND: In African Americans (AAs), APOL1 G1 and G2 nephropathy risk variants are associated with non-diabetic end-stage kidney disease (ESKD) in an autosomal recessive pattern. Additional risk and protective genetic variants may be present near the APOL1 loci, since earlier age ESKD is observed in some AAs with one APOL1 renal-risk variant, and because the adjacent gene MYH9 is associated with nephropathy in populations lacking G1 and G2 variants.
METHODS: Re-sequencing was performed across a ∼275 kb region encompassing the APOL1-APOL4 and MYH9 genes in 154 AA cases with non-diabetic ESKD and 38 controls without nephropathy who were heterozygous for a single APOL1 G1 or G2 risk variant.
RESULTS: Sequencing identified 3,246 non-coding single nucleotide polymorphisms (SNPs), 55 coding SNPs, and 246 insertion/deletions. No new coding variations were identified. Eleven variants, including a rare APOL3 Gln58Ter null variant (rs11089781), were genotyped in a replication panel of 1,571 AA ESKD cases and 1,334 controls. After adjusting for APOL1 G1 and G2 risk effects, these variations were not significantly associated with ESKD. In subjects with <2 APOL1 G1 and/or G2 alleles (849 cases; 1,139 controls), the APOL3 null variant was nominally associated with ESKD (recessive model, OR 1.81; p = 0.026); however, analysis in 807 AA cases and 634 controls from the Family Investigation of Nephropathy and Diabetes did not replicate this association.
CONCLUSION: Additional common variants in the APOL1-APOL4-MYH9 region do not contribute significantly to ESKD risk beyond the APOL1 G1 and G2 alleles.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26343748      PMCID: PMC4589514          DOI: 10.1159/000439448

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  26 in total

1.  Estimation of individual admixture: analytical and study design considerations.

Authors:  Hua Tang; Jie Peng; Pei Wang; Neil J Risch
Journal:  Genet Epidemiol       Date:  2005-05       Impact factor: 2.135

2.  APOL1 variants and kidney disease in people of recent African ancestry.

Authors:  Giulio Genovese; David J Friedman; Martin R Pollak
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

3.  Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.

Authors:  Jessica N Cooke; Meredith A Bostrom; Pamela J Hicks; Maggie C Y Ng; Jacklyn N Hellwege; Mary E Comeau; Jasmin Divers; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Nephrol Dial Transplant       Date:  2011-10-03       Impact factor: 5.992

4.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

5.  Genetic variation in APOL1 associates with younger age at hemodialysis initiation.

Authors:  Zahra Kanji; Camille E Powe; Julia B Wenger; Chunmei Huang; Elizabeth Ankers; Dorothy A Sullivan; Gina Collerone; Neil R Powe; Marcello Tonelli; Ishir Bhan; Andrea J Bernhardy; Salvatore Dibartolo; David Friedman; Giulio Genovese; Martin R Pollak; Ravi Thadhani
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

6.  APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.

Authors:  Shay Tzur; Saharon Rosset; Karl Skorecki; Walter G Wasser
Journal:  Nephrol Dial Transplant       Date:  2012-02-22       Impact factor: 5.992

7.  Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.

Authors:  Christopher P Larsen; Marjorie L Beggs; Mohammad Saeed; Patrick D Walker
Journal:  J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 10.121

8.  Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.

Authors:  Barry I Freedman; Carl D Langefeld; Jolyn Turner; Marina Núñez; Kevin P High; Mitzie Spainhour; Pamela J Hicks; Donald W Bowden; Amber M Reeves-Daniel; Mariana Murea; Michael V Rocco; Jasmin Divers
Journal:  Kidney Int       Date:  2012-06-13       Impact factor: 10.612

9.  Genome-wide association and functional follow-up reveals new loci for kidney function.

Authors:  Cristian Pattaro; Anna Köttgen; Alexander Teumer; Maija Garnaas; Carsten A Böger; Christian Fuchsberger; Matthias Olden; Ming-Huei Chen; Adrienne Tin; Daniel Taliun; Man Li; Xiaoyi Gao; Mathias Gorski; Qiong Yang; Claudia Hundertmark; Meredith C Foster; Conall M O'Seaghdha; Nicole Glazer; Aaron Isaacs; Ching-Ti Liu; Albert V Smith; Jeffrey R O'Connell; Maksim Struchalin; Toshiko Tanaka; Guo Li; Andrew D Johnson; Hinco J Gierman; Mary Feitosa; Shih-Jen Hwang; Elizabeth J Atkinson; Kurt Lohman; Marilyn C Cornelis; Åsa Johansson; Anke Tönjes; Abbas Dehghan; Vincent Chouraki; Elizabeth G Holliday; Rossella Sorice; Zoltan Kutalik; Terho Lehtimäki; Tõnu Esko; Harshal Deshmukh; Sheila Ulivi; Audrey Y Chu; Federico Murgia; Stella Trompet; Medea Imboden; Barbara Kollerits; Giorgio Pistis; Tamara B Harris; Lenore J Launer; Thor Aspelund; Gudny Eiriksdottir; Braxton D Mitchell; Eric Boerwinkle; Helena Schmidt; Margherita Cavalieri; Madhumathi Rao; Frank B Hu; Ayse Demirkan; Ben A Oostra; Mariza de Andrade; Stephen T Turner; Jingzhong Ding; Jeanette S Andrews; Barry I Freedman; Wolfgang Koenig; Thomas Illig; Angela Döring; H-Erich Wichmann; Ivana Kolcic; Tatijana Zemunik; Mladen Boban; Cosetta Minelli; Heather E Wheeler; Wilmar Igl; Ghazal Zaboli; Sarah H Wild; Alan F Wright; Harry Campbell; David Ellinghaus; Ute Nöthlings; Gunnar Jacobs; Reiner Biffar; Karlhans Endlich; Florian Ernst; Georg Homuth; Heyo K Kroemer; Matthias Nauck; Sylvia Stracke; Uwe Völker; Henry Völzke; Peter Kovacs; Michael Stumvoll; Reedik Mägi; Albert Hofman; Andre G Uitterlinden; Fernando Rivadeneira; Yurii S Aulchenko; Ozren Polasek; Nick Hastie; Veronique Vitart; Catherine Helmer; Jie Jin Wang; Daniela Ruggiero; Sven Bergmann; Mika Kähönen; Jorma Viikari; Tiit Nikopensius; Michael Province; Shamika Ketkar; Helen Colhoun; Alex Doney; Antonietta Robino; Franco Giulianini; Bernhard K Krämer; Laura Portas; Ian Ford; Brendan M Buckley; Martin Adam; Gian-Andri Thun; Bernhard Paulweber; Margot Haun; Cinzia Sala; Marie Metzger; Paul Mitchell; Marina Ciullo; Stuart K Kim; Peter Vollenweider; Olli Raitakari; Andres Metspalu; Colin Palmer; Paolo Gasparini; Mario Pirastu; J Wouter Jukema; Nicole M Probst-Hensch; Florian Kronenberg; Daniela Toniolo; Vilmundur Gudnason; Alan R Shuldiner; Josef Coresh; Reinhold Schmidt; Luigi Ferrucci; David S Siscovick; Cornelia M van Duijn; Ingrid Borecki; Sharon L R Kardia; Yongmei Liu; Gary C Curhan; Igor Rudan; Ulf Gyllensten; James F Wilson; Andre Franke; Peter P Pramstaller; Rainer Rettig; Inga Prokopenko; Jacqueline C M Witteman; Caroline Hayward; Paul Ridker; Afshin Parsa; Murielle Bochud; Iris M Heid; Wolfram Goessling; Daniel I Chasman; W H Linda Kao; Caroline S Fox
Journal:  PLoS Genet       Date:  2012-03-29       Impact factor: 5.917

10.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.

Authors:  Michael S Lipkowitz; Barry I Freedman; Carl D Langefeld; Mary E Comeau; Donald W Bowden; W H Linda Kao; Brad C Astor; Erwin P Bottinger; Sudha K Iyengar; Paul E Klotman; Richard G Freedman; Weijia Zhang; Rulan S Parekh; Michael J Choi; George W Nelson; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Kidney Int       Date:  2012-07-25       Impact factor: 10.612

View more
  8 in total

Review 1.  HDL in CKD-The Devil Is in the Detail.

Authors:  Florian Kronenberg
Journal:  J Am Soc Nephrol       Date:  2018-02-22       Impact factor: 10.121

2.  APOL1 gene variants and kidney disease in whites: the cardiovascular health study.

Authors:  Erika R Drury; David J Friedman; Martin R Pollak; Joachim H Ix; Lewis H Kuller; Russell P Tracy; Kenneth J Mukamal
Journal:  Nephrol Dial Transplant       Date:  2019-12-01       Impact factor: 5.992

3.  A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy.

Authors:  Karl L Skorecki; Jessica H Lee; Carl D Langefeld; Saharon Rosset; Shay Tzur; Walter G Wasser; Revital Shemer; Gregory A Hawkins; Jasmin Divers; Rulan S Parekh; Man Li; Matthew G Sampson; Matthias Kretzler; Martin R Pollak; Shrijal Shah; Daniel Blackler; Brendan Nichols; Michael Wilmot; Seth L Alper; Barry I Freedman; David J Friedman
Journal:  Nephrol Dial Transplant       Date:  2018-02-01       Impact factor: 5.992

Review 4.  Apolipoprotein L1 nephropathies: 2017 in review.

Authors:  Jeffrey B Kopp; Hila Roshanravan; Koji Okamoto
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-05       Impact factor: 2.894

5.  Racial differences in microRNA and gene expression in hypertensive women.

Authors:  Douglas F Dluzen; Nicole Noren Hooten; Yongqing Zhang; Yoonseo Kim; Frank E Glover; Salman M Tajuddin; Kimberly D Jacob; Alan B Zonderman; Michele K Evans
Journal:  Sci Rep       Date:  2016-10-25       Impact factor: 4.379

6.  G1 is the major APOL1 risk allele for hypertension-attributed nephropathy in Central Africa.

Authors:  Ernest K Sumaili; Revital Shemer; Etty Kruzel-Davila; Eric P Cohen; Pierre N Mutantu; Justine B Bukabau; Jean Robert R Makulo; Vieux M Mokoli; Jeannine L Luse; Nestor M Pakasa; Etienne Cavalier; Roger D Wumba; Anat Reiner-Benaim; Geoffrey Boner; Meyer Lifschitz; Nazaire M Nseka; Karl Skorecki; Walter G Wasser
Journal:  Clin Kidney J       Date:  2018-10-09

Review 7.  Genetic susceptibility of hypertension-induced kidney disease.

Authors:  Chao Zhang; Xing Fang; Huawei Zhang; Wenjun Gao; Han Jen Hsu; Richard J Roman; Fan Fan
Journal:  Physiol Rep       Date:  2021-01

8.  Association between MYH9 and APOL1 Gene Polymorphisms and the Risk of Diabetic Kidney Disease in Patients with Type 2 Diabetes in a Chinese Han Population.

Authors:  Hailing Zhao; Liang Ma; Meihua Yan; Yan Wang; Tingting Zhao; Haojun Zhang; Peng Liu; Yanzhen Liu; Ping Li
Journal:  J Diabetes Res       Date:  2018-05-09       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.